HuzefaJuzerMogriMD

Physician

Dr. Mogri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

12 citations
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy
Robbie G. Majzner, Huzefa J. Mogri, Ravi Varadhan, Patrick A. Brown, Kenneth R. Cooke
Biology of Blood and Marrow Transplantation. 2017-04-01
28 citations
Regulation of Ceramide Synthase by Casein Kinase 2-dependent Phosphorylation in Saccharomyces cerevisiae
Tara Fresques, Brad J. Niles, Sofia Aronova, Huzefa Mogri, Taha Rakhshandehroo
The Journal of Biological Chemistry. 2015-01-16
86 citations
Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-vers...
Jennifer A. Kanakry, Yvette L. Kasamon, Javier Bolaños-Meade, Ivan Borrello, Robert A. Brodsky
Biology of Blood and Marrow Transplantation. 2013-10-01

Journal Articles

Rarity of donor-derived malignancy after allogeneic BMT with high-dose post-transplantation cyclophosphamide.
Symons, H.J., Mogri, H., Kanakry, J.A., Ambinder, R., Luznik, L., Fuchs, E.J., Jones, R.J. and Kasamon, Y.L., Biology of Blood and Marrow Transplantation, 2014